ARCHIVES

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 15 | April 15, 2005

Download PDF Visit The Full Archive

Related Articles

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

Centers See Trend To Integrate Control Service With Science

February 18, 1983

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

May 30, 2014